Spinifex raises $6.3M; RXi gets green light for late-stage NeuVax study;

@FierceBiotech: Study aims decode baby DNA, create analysis tools. Story | Follow @FierceBiotech

@JohnCFierce: And now for something completely different. Russian agency backs upstart nano-bio with tailored pricing plan. Item | Follow @JohnCFierce

@RyanMFierce: @LifeSciVC (Bruce Booth) analyzes our shrinking biotech eco system, 27% drop in biopharmas over past 5 years Article | Follow @RyanMFierce

@MaureenFierce: RT @ldtimmerman: What most biotechies are missing on Twitter: A huge networking opportunity. Article | Follow @MaureenFierce

> Australia's Spinifex has raised $6.3 million from GBS Venture Partners and Brandon Capital Partners, bringing its total venture haul to $22.3 million. Story

> RXi Pharmaceuticals says that the FDA has lifted a partial clinical hold that had been delaying a late-stage study of its lead treatment NeuVax. RXi release

> Immunovaccine named Novavax veteran John J. Trizzino as its new chief executive officer. Novavax release

> Silence Therapeutics has forged a pact with InteRNA Technologies B.V. to develop novel microRNA therapeutics for cancer. Release

> Amicus Therapeutics and GlaxoSmithKline have begun dosing patients in a registration study comparing the efficacy of Amigal (migalastat HCl) and enzyme replacement therapy for the treatment of Fabry disease. Release

Pharma News

> Chinese outcry over Harbin unit's glitzy headquarters. Report

> FDA panel wants bone drugs' labeling changed, but how? Story

> Industry funding for CME falls 31% to $830M. Article

Biotech IT News

> Study aims decode baby DNA, create analysis tools. Article

> Scientists explore new model in battle against kidney disease. Report

> CLC bio building bioinformatics foundation for $4M cancer project. More

> U.K. groups building genomic cloud. Story

> Microsoft video-game tech used to detect illness. More

Medical Device News

> Valeritas completes $150M Series C round. News

> Masimo hit with patent lawsuit. Piece

> Cochlear shares take a dive on news of recall. Report

> Panel mulls tougher rules for transvaginal meshes. Item

And Finally... AVI staffers found inspiration for their work in the new Hollywood hit "Contagion." Story

Suggested Articles

Combining inhibitors of KRAS-G12C, mTOR and IGF1R can significantly shrink lung tumors in mice and human cancer cells, a study found.

X4 Pharmaceuticals has a new R&D chief: Renato Skerlj, who founded the company alongside CEO Paula Ragan and biotech luminary Henri Termeer.

Henlius Biotech missed the $477 million goal it set for its IPO, but still made the top five biopharma IPOs this year with its $410 million listing.